Cargando…
Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle‐directed enzyme prodrug therapy as a novel approach to cancer treatment
Directed enzyme prodrug therapy (DEPT) is a cancer chemotherapy strategy in which bacterial enzymes are delivered to a cancer site before prodrug administration, resulting in prodrug activation at the cancer site and more localized treatment. A major limitation to DEPT is the poor effectiveness of t...
Autores principales: | Ball, Patrick, Halliwell, Jennifer, Anderson, Simon, Gwenin, Vanessa, Gwenin, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568253/ https://www.ncbi.nlm.nih.gov/pubmed/32979040 http://dx.doi.org/10.1002/mbo3.1110 |
Ejemplares similares
-
The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach
por: Ball, Patrick, et al.
Publicado: (2021) -
Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy
por: Anderson, Simon D., et al.
Publicado: (2019) -
The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach
por: Ball, Patrick, et al.
Publicado: (2023) -
Magnetic Functionalized Nanoparticles for Biomedical, Drug Delivery and Imaging Applications
por: Anderson, Simon D., et al.
Publicado: (2019) -
Structural Factors That Determine the Activity of the Xenobiotic Reductase B Enzyme from Pseudomonas putida on Nitroaromatic Compounds
por: Osorio, Manuel I., et al.
Publicado: (2022)